Drug withdrawal and Hyperphagia: Lessons from Tobacco and other drugs

Current Pharmaceutical Design

Volumn 17, Issue 12, 2011, Pages 1173-1179

  Edge, Paula J ^a   Gold, Mark S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Dopamine; Hyperphagia; Metabolic syndrome; Reward pathways; Type 2 diabetes mellitus; Withdrawal

Indexed keywords

AMPHETAMINE; LUBRICATING AGENT;

ADDICTION; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; CIGARETTE SMOKING; COCAINE DEPENDENCE; DRUG DEPENDENCE; DRUG WITHDRAWAL; EMPIRICAL RESEARCH; FOOD ADDICTION; HUMAN; HYPERPHAGIA; NICOTINE REPLACEMENT THERAPY; NONHUMAN; OBESITY; PARKINSON DISEASE; PRIORITY JOURNAL; SMOKING CESSATION; TOBACCO; TOBACCO DEPENDENCE;

EID: 79958239587     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211795656738     Document Type: Article

References (76)

1. Bifulco M, Caruso MG. From the gastronomic revolution to thenew globesity epidemic. Journal of the American DieteticAssociation 2007; 107(12): 2058-60.
2. Deitel M. The International Obesity Task Force and globesity.Obesity surgery 2002 Oct; 12(5): 613-4.
3. Blumenthal DM, Gold MS. Neurobiology of food addiction.Current opinion in clinical nutrition and metabolic care 2010; 13:359-65.
4. Blum K, Chen TJ, Chen AL, Madigan M, Downs BW, Waite RL, et al. Do dopaminergic gene polymorphisms affect mesolimbicreward activation of music listening response? Therapeutic impacton Reward Deficiency Syndrome (RDS). Medical hypotheses 2010; 74(3): 513-20.
5. Blum K, Gold MS. Neuro-chemical activation of brain rewardmeso-limbic circuitry is associated with relapse prevention anddrug hunger: A hypothesis. Medical hypotheses 2011.
6. Gold MS, Miller NS. Intoxication and withdrawal from nicotine,cocaine and amphetamines. In: Miller NS, Gold MS, Smith DE,editors. Manual of Therapeutics for Addictions. New York: Wiley-Liss; 1997.
7. Gold MS. Are eating disorders addictions? Neuro Endocrinol Lett 1992; 14(4): 229.
8. Gold MS. Eating disorders, overeating, and pathologicalattachment to food: independent or addictive disorders? Journal ofaddictive diseases 2004; 23(3): 1-3.
9. Gold MS, Graham NA, Cocores JA, Nixon SJ. Food addiction? JAddict Med 2009; 3(1): 42-5.
10. Warren MW, Gold MS. The relationship between obesity and druguse. The American journal of psychiatry 2007; 164(8): 1268;author reply -9.
11. Legakis I, Syrigos K. Obesity modulation - the role incarcinogenesis. Anticancer Agents Med Chem 2010; 10(6): 481-90.
12. Graham NA, Frost-Pineda K, Gold MS. Tobacco and psychiatricdual disorders. Journal of addictive diseases 2007; 26 Suppl 1: 5-12.
13. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotinedependence and psychiatric disorders in the United States: resultsfrom the national epidemiologic survey on alcohol and relatedconditions. Archives of general psychiatry 2004; 61(11): 1107-15.
14. Barry D, Petry NM. Associations between body mass index andsubstance use disorders differ by gender: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addictive behaviors 2009; 34(1): 51-60.
15. Shriner RL, Graham NA, Gold MS. Smoking cessation and the riskfor type 2 diabetes mellitus. Annals of internal medicine 2010;152(11): 755; author reply -6.
16. Hodgkins CC, Cahill KS, Seraphine AE, Frost-Pineda K, Gold MS. Adolescent drug addiction treatment and weight gain. Journal ofaddictive diseases 2004; 23(3): 55-65.
17. Anzengruber D, Klump KL, Thornton L, Brandt H, Crawford S, Fichter MM, et al. Smoking in eating disorders. Eating behaviors 2006; 7(4): 291-9.
18. Goldfield GS, Lumb A. Smoking, dietary restraint, gender, and therelative reinforcing value of snack food in a large universitysample. Appetite 2008; 50(2-3): 278-89.
19. Cocores JA, Gold MS. The Salted Food Addiction Hypothesis mayexplain overeating and the obesity epidemic. Medical hypotheses 2009; 73(6): 892-9.
20. Caggiula AR, Donny EC, White AR, et al. Cue dependency ofnicotine self-administration and smoking. Pharmacology,biochemistry, and behavior 2001; 70(4): 515-30.
21. Schroeder BE, Binzak JM, Kelley AE. A common profile ofprefrontal cortical activation following exposure to nicotine- orchocolate-associated contextual cues. Neuroscience 2001; 105(3):535-45.
22. von der Goltz C, Koopmann A, Dinter C, et al. Orexin and leptinare associated with nicotine craving: a link between smoking,appetite and reward. Psychoneuroendocrinology 2010; 35(4): 570-7.
23. al'Absi M, Hooker S, Fujiwara K, et al. Circulating leptin levels areassociated with increased craving to smoke in abstinent smokers. Pharmacology, biochemistry, and behavior 2011; 97(3): 509-13.
24. Dandekar MP, Nakhate KT, Kokare DM, Subhedar NK. Effect ofnicotine on feeding and body weight in rats: Involvement ofcocaine- and amphetamine-regulated transcript peptide. Behavioural brain research 2011 Epub on Dec 13; 219(1): 31-8.
25. Leeman RF, O'Malley SS, White MA, McKee SA. Nicotine andfood deprivation decrease the ability to resist smoking. Psychopharmacology 2010; 212(1): 25-32.
26. Mooney ME, Sofuoglu M. Bupropion for the treatment of nicotinewithdrawal and craving. Expert Rev Neurother 2006; 6(7): 965-81.
27. Garrison GD, Dugan SE. Varenicline: a first-line treatment optionfor smoking cessation. Clinical therapeutics 2009; 31(3): 463-91.
28. Parsons AC, Shraim M, Inglis J, Aveyard P, Hajek P. Interventionsfor preventing weight gain after smoking cessation. Cochranedatabase of systematic reviews (Online) 2009(1): CD006219.
29. Katcher BS. Benjamin Rush's educational campaign against harddrinking. American journal of public health 1993; 83(2): 273-81.
30. Kleiner KD, Gold MS, Frost-Pineda K, Lenz-Brunsman B, Perri MG, Jacobs WS. Body mass index and alcohol use. Journal ofaddictive diseases 2004; 23(3): 105-18.
31. DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS. Settingthe standard for recovery: Physicians health programs. Journal ofsubstance abuse treatment 2009; 36(2): 159-71.
32. Krahn D, Grossman J, Henk H, Mussey M, Crosby R, Gosnell B. Sweet intake, sweet-liking, urges to eat, and weight change:relationship to alcohol dependence and abstinence. Addictivebehaviors 2006; 31(4): 622-31.
33. Halladay AK, Fisher H, Wagner GC. Effects of phentermine andfenfluramine on alcohol consumption and alcohol withdrawalseizures in rats. Alcohol (Fayetteville, NY 2000; 20(1): 19-29.
34. Heilig M, Egli M, Crabbe JC, Becker HC. Acute withdrawal,protracted abstinence and negative affect in alcoholism: are theylinked? Addiction biology 2010; 15(2): 169-84.
35. Rada P, Barson JR, Leibowitz SF, Hoebel BG. Opioids in thehypothalamus control dopamine and acetylcholine levels in thenucleus accumbens. Brain Res 2010; 1312: 1-9.
36. Barson JR, Carr AJ, Soun JE, et al. Opioids in the hypothalamicparaventricular nucleus stimulate ethanol intake. Alcoholism,clinical and experimental research 2010; 34(2): 214-22.
37. Kiefer F, Jahn H, Otte C, Demiralay C, Wolf K, Wiedemann K.Increasing leptin precedes craving and relapse duringpharmacological abstinence maintenance treatment of alcoholism. Journal of psychiatric research 2005; 39(5): 545-51.
38. Landgren S, Simms JA, Hyytia P, Engel JA, Bartlett SE, Jerlhag E. Ghrelin receptor (GHS-R1A) antagonism suppresses both operantalcohol self-administration and high alcohol consumption in rats. Addiction biology 2011 Feb 11.
39. Kirkham TC. Cannabinoids and appetite: food craving and foodpleasure. Int Rev Psychiatry 2009; 21(2): 163-71.
40. Dodd GT, Stark JA, McKie S, Williams SR, Luckman SM. Centralcannabinoid signaling mediating food intake: a pharmacologicalchallengemagnetic resonance imaging and functional histologystudy in rat. Neuroscience 2009; 163(4): 1192-200.
41. Kirkham TC, Barber DJ, Heath RW, Cooper SJ. Differential effectsof CGS 8216 and naltrexone on ingestional behaviour. Pharmacology, biochemistry, and behavior 1987; 26(1): 145-51.
42. Kirkham TC, Williams CM, Fezza F, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamusin relation to fasting, feeding and satiation: stimulation of eating by2-arachidonoyl glycerol. British journal of pharmacology 2002;136(4): 550-7.
43. Gold MS, Frost-Pineda K, Jacobs WS. Cannabis. In: Gallanter M, Kleber HD, editors. Textbook of Substance Abuse Treatment, Third Edition. New York: American Psychiatric Publications, Inc.; 2004. p. 167-88.
44. Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV. Dronabinol for the treatment of cannabis dependence: Arandomized, double-blind, placebo-controlled trial. Drug andalcohol dependence 2011 Feb 8.
45. Farrimond JA, Mercier MS, Whalley BJ, Williams CM. Cannabissativa and the endogenous cannabinoid system: therapeuticpotential for appetite regulation. Phytother Res 2011; 25(2): 170-88.
46. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders - 4th edition (DSM-IV). Washington,DC: American Psychiatric Association; 1994.
47. Leventhal AM, Kahler CW, Ray LA, et al. Anhedonia andamotivation in psychiatric outpatients with fully remitted stimulantuse disorder. The American journal on addictions / AmericanAcademy of Psychiatrists in Alcoholism and Addictions 2008;17(3): 218-23.
48. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity ofmethamphetamine withdrawal. Addiction (Abingdon, England) 2005; 100(9): 1320-9.
49. Dutta S, Morton J, Shepard E, et al. Methamphetamine usefollowing bariatric surgery in an adolescent. Obesity surgery 2006;16(6): 780-2.
50. Der-Avakian A, Markou A. Withdrawal from chronic exposure toamphetamine, but not nicotine, leads to an immediate and enduringdeficit in motivated behavior without affecting social interaction inrats. Behavioural pharmacology 2010; 21(4): 359-68.
51. Gold MS, Kobeissy FH, Wang KK, et al. Methamphetamine-andtrauma-induced brain injuries: comparative cellular and molecularneurobiological substrates. Biological psychiatry 2009; 66(2): 118-27.
52. Jonas JM, Gold MS. Cocaine abuse and eating disorders. Lancet 1986; 1(8477): 390-1.
53. Paczynski RP, Gold MS. Cocaine and Crack. In: Ruiz P, Strain E,editors. Lowinson & Ruiz's Substance Abuse: A Comprehensive Textbook, 5th Edition. Baltimore: MD: Lippincott Williams & Wilkins; 2011 Apr.
54. Dackis CA, Gold MS. New concepts in cocaine addiction: thedopamine depletion hypothesis. Neurosci Bio Rev 1985; 9: 469-77.
55. Dackis CA, Gold MS. Biological aspects of cocaine addiction. In:Volkow ND, Swann AC, editors. Cocaine in the brain. NewBrunswick, NJ: Rutgers University Press; 1988.
56. Gold MS. Cocaine. Drugs of Abuse: A Comprehensive Series for Clinicians, Vol III. New York and London: Plenum Press; 1993.
57. Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. Newonset heightened interest or drive for gambling, shopping, eating orsexual activity in patients with Parkinson's disease: the role ofdopamine agonist treatment and age at motor symptoms onset. Journal of psychopharmacology (Oxford, England) 2007; 21(5):501-6.
58. Zahodne LB, Susatia F, Bowers D, Ong TL, Jacobson CEt, Okun MS, et al. Binge eating in Parkinson's disease: prevalence,correlates and the contribution of deep brain stimulation. The Journal of neuropsychiatry and clinical neurosciences 2011; 23(1):56-62.
59. Hassan A, Bower JH, Kumar N, et al. Dopamine agonist-triggeredpathological behaviors: Surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord 2011 Feb 8.
60. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Imaging of braindopamine pathways: Implications for understanding obesity. J Addict Med 2009; 3(1): 8-18.
61. Dagher A. The neurobiology of appetite: hunger as addiction. International journal of obesity (2005) 2009; 33 Suppl 2: S30-3.
62. Avena NM, Rada P, Hoebel BG. Evidence for sugar addiction:behavioral and neurochemical effects of intermittent, excessivesugar intake. Neurosci Biobehav Rev 2008; 32(1): 20-39.
63. Avena NM, Rada P, Hoebel BG. Sugar and fat bingeing havenotable differences in addictive-like behavior. The Journal ofnutrition 2009; 139(3): 623-8.
64. Liu Y, Gold MS. Human functional Magnetic Resonance Imaging(fMRI) of eating and satiety in eating disorders and obesity. Psychiatric Annals 2003; 33(2): 127-32.
65. Taylor PD, Poston L. Developmental programming of obesity inmammals. Experimental physiology 2007; 92(2): 287-98.
66. Sullivan EL, Smith MS, Grove KL. Perinatal Exposure to High-FatDiet Programs Energy Balance, Metabolism and Behavior in Adulthood. Neuroendocrinology 2010 Nov 13.
67. Mazzeo SE, Mitchell KS, Bulik CM, Reichborn-Kjennerud T, Kendler KS, Neale MC. Assessing the heritability of anorexianervosa symptoms using a marginal maximal likelihood approach. Psychol Med 2009; 39(3): 463-73.
68. Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL. Prevalence, heritability, and prospective risk factorsfor anorexia nervosa. Archives of general psychiatry 2006; 63(3):305-12.
69. Liu Y, Von Deneen KM, Kobeissy F, Gold MS. Food Addictionand Obesity: Evidence from Bench to Bedside. Journal ofpsychoactive drugs 2010; 42(2): 133-51.
70. James GA, Gold MS, Liu Y. Interaction of satiety and rewardresponse to food stimulation. Journal of addictive diseases 2004;23(3): 23-37.
71. O'Sullivan SS, Wu K, Politis M, et al. Cue-induced striataldopamine release in Parkinson's disease-associated impulsivecompulsivebehaviours. Brain 2011 Feb 24.
72. Lester BM, Padbury JF. Third pathophysiology of prenatal cocaineexposure. Dev Neurosci 2009; 31(1-2): 23-35.
73. Lagasse LL, Gaskins RB, Bada HS, et al. Prenatal cocaineexposure and childhood obesity at nine years. Neurotoxicology andteratology 2010 Nov 23.
74. Edens E, Massa A, Petrakis I. Novel pharmacological approaches to drug abuse treatment. Current topics in behavioral neurosciences 2010; 3: 343-86.
75. Nathan PJ, O'Neill BV, Napolitano A, Bullmore ET. Neuropsychiatric Adverse Effects of Centrally Acting Antiobesity Drugs. CNS Neurosci Ther 2010 Jul 7.
76. Avena NM. The study of food addiction using animal models ofbinge eating. Appetite 2010; 55(3): 734-7.